|False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?|
M Farhat, C Greenaway, M Pai, D Menzies
The International Journal of Tuberculosis and Lung Disease 10 (11), 1192-1204, 2006
|Evidence-based clinical guidelines for immigrants and refugees|
K Pottie, C Greenaway, J Feightner, V Welch, H Swinkels, M Rashid, ...
Cmaj 183 (12), E824-E925, 2011
|Delay in diagnosis among hospitalized patients with active tuberculosis—predictors and outcomes|
C Greenaway, D Menzies, A Fanning, R Grewal, L Yuan, ...
American journal of respiratory and critical care medicine 165 (7), 927-933, 2002
|The impact of migration on tuberculosis epidemiology and control in high-income countries: a review|
M Pareek, C Greenaway, T Noori, J Munoz, D Zenner
BMC medicine 14 (1), 1-10, 2016
|Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis|
C Rossi, I Shrier, L Marshall, S Cnossen, K Schwartzman, MB Klein, ...
PloS one 7 (9), e44611, 2012
|Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network|
AK Boggild, F Castelli, P Gautret, J Torresi, F von Sonnenburg, ED Barnett, ...
Vaccine 28 (46), 7389-7395, 2010
|Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results|
D Menzies, G Gardiner, M Farhat, C Greenaway, M Pai
The International Journal of Tuberculosis and Lung Disease 12 (5), 498-505, 2008
|Tuberculosis: evidence review for newly arriving immigrants and refugees|
C Greenaway, A Sandoe, B Vissandjee, I Kitai, D Gruner, W Wobeser, ...
Cmaj 183 (12), E939-E951, 2011
|The seroprevalence of hepatitis C antibodies in immigrants and refugees from intermediate and high endemic countries: a systematic review and meta-analysis|
C Greenaway, AT Ma, LA Kloda, M Klein, S Cnossen, G Schwarzer, ...
PloS one 10 (11), e0141715, 2015
|Dracunculiasis (guinea worm disease)|
Cmaj 170 (4), 495-500, 2004
|Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis|
SA Turner, JD Maclean, L Fleckenstein, C Greenaway
The American journal of tropical medicine and hygiene 73 (5), 911-914, 2005
|Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997–2009, part 2: migrants resettled internationally and evaluated for specific health concerns|
AE McCarthy, LH Weld, ED Barnett, H So, C Coyle, C Greenaway, ...
Clinical infectious diseases 56 (7), 925-933, 2013
|Risk of active tuberculosis in patients with cancer: a systematic review and metaanalysis|
MP Cheng, CNA Chakra, CP Yansouni, S Cnossen, I Shrier, D Menzies, ...
Clinical Infectious Diseases 64 (5), 635-644, 2017
|Comparison of LED and conventional fluorescence microscopy for detection of acid fast bacilli in a low-incidence setting|
J Minion, M Pai, A Ramsay, D Menzies, C Greenaway
PLoS One 6 (7), e22495, 2011
|Vaccine‐Preventable Travel Health Risks: What Is the Evidence—What Are the Gaps?|
R Steffen, RH Behrens, DR Hill, C Greenaway, K Leder
Journal of travel medicine 22 (1), 1-12, 2015
|Susceptibility to measles, mumps, and rubella in newly arrived adult immigrants and refugees|
C Greenaway, P Dongier, JF Boivin, B Tapiero, M Miller, K Schwartzman
Annals of internal medicine 146 (1), 20-24, 2007
|The evolving epidemiology of chlamydial and gonococcal infections in response to control programs in Winnipeg, Canada.|
JF Blanchard, S Moses, C Greenaway, P Orr, GW Hammond, ...
American journal of public health 88 (10), 1496-1502, 1998
|The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review|
C Greenaway, M Pareek, CN Abou Chakra, M Walji, I Makarenko, ...
Eurosurveillance 23 (14), 17-00543, 2018
|Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis|
C Rossi, K Schwartzman, O Oxlade, MB Klein, C Greenaway
PloS one 8 (10), e78548, 2013
|Risk assessment in Travel medicine: how to obtain, interpret, and use risk data for informing pre‐travel advice|
K Leder, R Steffen, JP Cramer, C Greenaway
Journal of travel medicine 22 (1), 13-20, 2015